glp 1 drugs zepbound GLP1 Drug Use For Weight Loss Has Soared Costing Billions Eli Lilly strikes Zepbound deal

GLP-1 Agonists with SGLT-2 Inhibitors SGLT-2 inhibitors, used in diabetes treatment, may synergize with GLP-1 agonists to enhance weight loss and reduce cardiovascular risk

Front Pharmacol (2020) 11:356

Although the occurrence of EDKA associated with SGLT2 inhibitors is rather rare, several predisposing factors have been recognised

Targeted estrogen delivery reverses the metabolic syndrome

Tirzepatide is the first dual agonist which has been approved for chronic weight management, but numerous other dual and/or triple agonists (cagrisema, retatrutide, mazdutide and survodutide) are also in phase 3 trials as potential treatments for obesity and its metabolic complications

In Ldlr / mice on a 40% high-fat diet for 17 weeks, daily administration of semaglutide at 4, 12, or 60 g/kg downregulated collagen genes and immune-related genes including S100a8 , S100a9 , Timp1 , Tlr2 , and Cx3cr1 (21)